COVID-19 Impact on Global Allergic Asthma Therapeutics Market Size, Status and Forecast 2020-2026

September 2020 | 127 pages | ID: C86D60A50E32EN
QYResearch

Abstracts

This report focuses on the global Allergic Asthma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Allergic Asthma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Aslan Pharmaceuticals Pte. Ltd.
• Axikin Pharmaceuticals, Inc.
• Baxalta Incorporated
• Chiesi Farmaceutici SpA
• Circassia Pharmaceuticals Plc
• CSL Limited
• Fountain Biopharma Inc.
• GlaxoSmithKline Plc
• Hydra Biosciences, Inc.
• Infinity Pharmaceuticals, Inc.
• Kineta, Inc.
• Mabtech Limited
• Marinomed Biotechnologie GmbH
• Mycenax Biotech Inc.
• NeoPharm Co., Ltd.
• Oxagen Limited
• Panacea Biotec Limited

Market segment by Type, the product can be split into

• ASM-8
• AXP-1275
• Beta-escin
• CHF-6001
• CSL-311
• Dalazatide
• Others

Market segment by Application, split into

• Clinic
• Research Center
• Hospital
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Allergic Asthma Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Allergic Asthma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Allergic Asthma Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 ASM-8
  1.4.3 AXP-1275
  1.4.4 Beta-escin
  1.4.5 CHF-6001
  1.4.6 CSL-311
  1.4.7 Dalazatide
  1.4.8 Others
1.5 Market by Application
  1.5.1 Global Allergic Asthma Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Research Center
  1.5.4 Hospital
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Allergic Asthma Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Allergic Asthma Therapeutics Industry
    1.6.1.1 Allergic Asthma Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Allergic Asthma Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Allergic Asthma Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Allergic Asthma Therapeutics Market Perspective (2015-2026)
2.2 Allergic Asthma Therapeutics Growth Trends by Regions
  2.2.1 Allergic Asthma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Allergic Asthma Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Allergic Asthma Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Allergic Asthma Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Allergic Asthma Therapeutics Players by Market Size
  3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Allergic Asthma Therapeutics Market Concentration Ratio
  3.2.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2019
3.3 Allergic Asthma Therapeutics Key Players Head office and Area Served
3.4 Key Players Allergic Asthma Therapeutics Product Solution and Service
3.5 Date of Enter into Allergic Asthma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2021-2026)

5 ALLERGIC ASTHMA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Allergic Asthma Therapeutics Market Size by Application (2015-2020)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Allergic Asthma Therapeutics Market Size (2015-2020)
6.2 Allergic Asthma Therapeutics Key Players in North America (2019-2020)
6.3 North America Allergic Asthma Therapeutics Market Size by Type (2015-2020)
6.4 North America Allergic Asthma Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Allergic Asthma Therapeutics Market Size (2015-2020)
7.2 Allergic Asthma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Allergic Asthma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Allergic Asthma Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Allergic Asthma Therapeutics Market Size (2015-2020)
8.2 Allergic Asthma Therapeutics Key Players in China (2019-2020)
8.3 China Allergic Asthma Therapeutics Market Size by Type (2015-2020)
8.4 China Allergic Asthma Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Allergic Asthma Therapeutics Market Size (2015-2020)
9.2 Allergic Asthma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Allergic Asthma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Allergic Asthma Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Allergic Asthma Therapeutics Market Size (2015-2020)
10.2 Allergic Asthma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Allergic Asthma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Allergic Asthma Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Allergic Asthma Therapeutics Market Size (2015-2020)
11.2 Allergic Asthma Therapeutics Key Players in India (2019-2020)
11.3 India Allergic Asthma Therapeutics Market Size by Type (2015-2020)
11.4 India Allergic Asthma Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Allergic Asthma Therapeutics Market Size (2015-2020)
12.2 Allergic Asthma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Allergic Asthma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Allergic Asthma Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Aslan Pharmaceuticals Pte. Ltd.
  13.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Details
  13.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview and Its Total Revenue
  13.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
  13.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2015-2020))
  13.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
13.2 Axikin Pharmaceuticals, Inc.
  13.2.1 Axikin Pharmaceuticals, Inc. Company Details
  13.2.2 Axikin Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
  13.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.2.5 Axikin Pharmaceuticals, Inc. Recent Development
13.3 Baxalta Incorporated
  13.3.1 Baxalta Incorporated Company Details
  13.3.2 Baxalta Incorporated Business Overview and Its Total Revenue
  13.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
  13.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.3.5 Baxalta Incorporated Recent Development
13.4 Chiesi Farmaceutici SpA
  13.4.1 Chiesi Farmaceutici SpA Company Details
  13.4.2 Chiesi Farmaceutici SpA Business Overview and Its Total Revenue
  13.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
  13.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.4.5 Chiesi Farmaceutici SpA Recent Development
13.5 Circassia Pharmaceuticals Plc
  13.5.1 Circassia Pharmaceuticals Plc Company Details
  13.5.2 Circassia Pharmaceuticals Plc Business Overview and Its Total Revenue
  13.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
  13.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.5.5 Circassia Pharmaceuticals Plc Recent Development
13.6 CSL Limited
  13.6.1 CSL Limited Company Details
  13.6.2 CSL Limited Business Overview and Its Total Revenue
  13.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
  13.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.6.5 CSL Limited Recent Development
13.7 Fountain Biopharma Inc.
  13.7.1 Fountain Biopharma Inc. Company Details
  13.7.2 Fountain Biopharma Inc. Business Overview and Its Total Revenue
  13.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
  13.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.7.5 Fountain Biopharma Inc. Recent Development
13.8 GlaxoSmithKline Plc
  13.8.1 GlaxoSmithKline Plc Company Details
  13.8.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  13.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
  13.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.8.5 GlaxoSmithKline Plc Recent Development
13.9 Hydra Biosciences, Inc.
  13.9.1 Hydra Biosciences, Inc. Company Details
  13.9.2 Hydra Biosciences, Inc. Business Overview and Its Total Revenue
  13.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
  13.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.9.5 Hydra Biosciences, Inc. Recent Development
13.10 Infinity Pharmaceuticals, Inc.
  13.10.1 Infinity Pharmaceuticals, Inc. Company Details
  13.10.2 Infinity Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
  13.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  13.10.5 Infinity Pharmaceuticals, Inc. Recent Development
13.11 Kineta, Inc.
  10.11.1 Kineta, Inc. Company Details
  10.11.2 Kineta, Inc. Business Overview and Its Total Revenue
  10.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
  10.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.11.5 Kineta, Inc. Recent Development
13.12 Mabtech Limited
  10.12.1 Mabtech Limited Company Details
  10.12.2 Mabtech Limited Business Overview and Its Total Revenue
  10.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
  10.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.12.5 Mabtech Limited Recent Development
13.13 Marinomed Biotechnologie GmbH
  10.13.1 Marinomed Biotechnologie GmbH Company Details
  10.13.2 Marinomed Biotechnologie GmbH Business Overview and Its Total Revenue
  10.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
  10.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.13.5 Marinomed Biotechnologie GmbH Recent Development
13.14 Mycenax Biotech Inc.
  10.14.1 Mycenax Biotech Inc. Company Details
  10.14.2 Mycenax Biotech Inc. Business Overview and Its Total Revenue
  10.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
  10.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.14.5 Mycenax Biotech Inc. Recent Development
13.15 NeoPharm Co., Ltd.
  10.15.1 NeoPharm Co., Ltd. Company Details
  10.15.2 NeoPharm Co., Ltd. Business Overview and Its Total Revenue
  10.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
  10.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.15.5 NeoPharm Co., Ltd. Recent Development
13.16 Oxagen Limited
  10.16.1 Oxagen Limited Company Details
  10.16.2 Oxagen Limited Business Overview and Its Total Revenue
  10.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
  10.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.16.5 Oxagen Limited Recent Development
13.17 Panacea Biotec Limited
  10.17.1 Panacea Biotec Limited Company Details
  10.17.2 Panacea Biotec Limited Business Overview and Its Total Revenue
  10.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
  10.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020)
  10.17.5 Panacea Biotec Limited Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Allergic Asthma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
Table 3. Ranking of Global Top Allergic Asthma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Allergic Asthma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ASM-8
Table 6. Key Players of AXP-1275
Table 7. Key Players of Beta-escin
Table 8. Key Players of CHF-6001
Table 9. Key Players of CSL-311
Table 10. Key Players of Dalazatide
Table 11. Key Players of Others
Table 12. COVID-19 Impact Global Market: (Four Allergic Asthma Therapeutics Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Allergic Asthma Therapeutics Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Allergic Asthma Therapeutics Players to Combat Covid-19 Impact
Table 17. Global Allergic Asthma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Allergic Asthma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Allergic Asthma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Market Share by Regions (2015-2020)
Table 21. Global Allergic Asthma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Allergic Asthma Therapeutics Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Allergic Asthma Therapeutics Market Growth Strategy
Table 27. Main Points Interviewed from Key Allergic Asthma Therapeutics Players
Table 28. Global Allergic Asthma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 29. Global Allergic Asthma Therapeutics Market Share by Players (2015-2020)
Table 30. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Asthma Therapeutics as of 2019)
Table 31. Global Allergic Asthma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Allergic Asthma Therapeutics Product Solution and Service
Table 34. Date of Enter into Allergic Asthma Therapeutics Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. Global Allergic Asthma Therapeutics Market Size Share by Type (2015-2020)
Table 38. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2021-2026)
Table 39. Global Allergic Asthma Therapeutics Market Size Share by Application (2015-2020)
Table 40. Global Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. Global Allergic Asthma Therapeutics Market Size Share by Application (2021-2026)
Table 42. North America Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 44. North America Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. North America Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 46. North America Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. North America Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 48. Europe Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 50. Europe Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 52. Europe Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 54. China Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 55. China Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 56. China Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. China Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 58. China Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. China Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 60. Japan Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 62. Japan Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 64. Japan Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 68. Southeast Asia Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 70. Southeast Asia Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 72. India Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 73. India Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 74. India Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. India Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 76. India Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. India Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Allergic Asthma Therapeutics Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Allergic Asthma Therapeutics Market Share (2019-2020)
Table 80. Central & South America Allergic Asthma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Allergic Asthma Therapeutics Market Share by Type (2015-2020)
Table 82. Central & South America Allergic Asthma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Allergic Asthma Therapeutics Market Share by Application (2015-2020)
Table 84. Aslan Pharmaceuticals Pte. Ltd. Company Details
Table 85. Aslan Pharmaceuticals Pte. Ltd. Business Overview
Table 86. Aslan Pharmaceuticals Pte. Ltd. Product
Table 87. Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 88. Aslan Pharmaceuticals Pte. Ltd. Recent Development
Table 89. Axikin Pharmaceuticals, Inc. Company Details
Table 90. Axikin Pharmaceuticals, Inc. Business Overview
Table 91. Axikin Pharmaceuticals, Inc. Product
Table 92. Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 93. Axikin Pharmaceuticals, Inc. Recent Development
Table 94. Baxalta Incorporated Company Details
Table 95. Baxalta Incorporated Business Overview
Table 96. Baxalta Incorporated Product
Table 97. Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 98. Baxalta Incorporated Recent Development
Table 99. Chiesi Farmaceutici SpA Company Details
Table 100. Chiesi Farmaceutici SpA Business Overview
Table 101. Chiesi Farmaceutici SpA Product
Table 102. Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 103. Chiesi Farmaceutici SpA Recent Development
Table 104. Circassia Pharmaceuticals Plc Company Details
Table 105. Circassia Pharmaceuticals Plc Business Overview
Table 106. Circassia Pharmaceuticals Plc Product
Table 107. Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 108. Circassia Pharmaceuticals Plc Recent Development
Table 109. CSL Limited Company Details
Table 110. CSL Limited Business Overview
Table 111. CSL Limited Product
Table 112. CSL Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 113. CSL Limited Recent Development
Table 114. Fountain Biopharma Inc. Company Details
Table 115. Fountain Biopharma Inc. Business Overview
Table 116. Fountain Biopharma Inc. Product
Table 117. Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 118. Fountain Biopharma Inc. Recent Development
Table 119. GlaxoSmithKline Plc Business Overview
Table 120. GlaxoSmithKline Plc Product
Table 121. GlaxoSmithKline Plc Company Details
Table 122. GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 123. GlaxoSmithKline Plc Recent Development
Table 124. Hydra Biosciences, Inc. Company Details
Table 125. Hydra Biosciences, Inc. Business Overview
Table 126. Hydra Biosciences, Inc. Product
Table 127. Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 128. Hydra Biosciences, Inc. Recent Development
Table 129. Infinity Pharmaceuticals, Inc. Company Details
Table 130. Infinity Pharmaceuticals, Inc. Business Overview
Table 131. Infinity Pharmaceuticals, Inc. Product
Table 132. Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 133. Infinity Pharmaceuticals, Inc. Recent Development
Table 134. Kineta, Inc. Company Details
Table 135. Kineta, Inc. Business Overview
Table 136. Kineta, Inc. Product
Table 137. Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 138. Kineta, Inc. Recent Development
Table 139. Mabtech Limited Company Details
Table 140. Mabtech Limited Business Overview
Table 141. Mabtech Limited Product
Table 142. Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 143. Mabtech Limited Recent Development
Table 144. Marinomed Biotechnologie GmbH Company Details
Table 145. Marinomed Biotechnologie GmbH Business Overview
Table 146. Marinomed Biotechnologie GmbH Product
Table 147. Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 148. Marinomed Biotechnologie GmbH Recent Development
Table 149. Mycenax Biotech Inc. Company Details
Table 150. Mycenax Biotech Inc. Business Overview
Table 151. Mycenax Biotech Inc. Product
Table 152. Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 153. Mycenax Biotech Inc. Recent Development
Table 154. NeoPharm Co., Ltd. Company Details
Table 155. NeoPharm Co., Ltd. Business Overview
Table 156. NeoPharm Co., Ltd. Product
Table 157. NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 158. NeoPharm Co., Ltd. Recent Development
Table 159. Oxagen Limited Company Details
Table 160. Oxagen Limited Business Overview
Table 161. Oxagen Limited Product
Table 162. Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 163. Oxagen Limited Recent Development
Table 164. Panacea Biotec Limited Company Details
Table 165. Panacea Biotec Limited Business Overview
Table 166. Panacea Biotec Limited Product
Table 167. Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2015-2020) (Million US$)
Table 168. Panacea Biotec Limited Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Allergic Asthma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. ASM-8 Features
Figure 3. AXP-1275 Features
Figure 4. Beta-escin Features
Figure 5. CHF-6001 Features
Figure 6. CSL-311 Features
Figure 7. Dalazatide Features
Figure 8. Others Features
Figure 9. Global Allergic Asthma Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Clinic Case Studies
Figure 11. Research Center Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Allergic Asthma Therapeutics Report Years Considered
Figure 15. Global Allergic Asthma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Allergic Asthma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 17. Global Allergic Asthma Therapeutics Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Allergic Asthma Therapeutics Market Share by Players in 2019
Figure 20. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Asthma Therapeutics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Allergic Asthma Therapeutics Revenue in 2019
Figure 22. North America Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Allergic Asthma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Aslan Pharmaceuticals Pte. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Aslan Pharmaceuticals Pte. Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 31. Axikin Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Axikin Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 33. Baxalta Incorporated Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Baxalta Incorporated Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 35. Chiesi Farmaceutici SpA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Chiesi Farmaceutici SpA Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 37. Circassia Pharmaceuticals Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Circassia Pharmaceuticals Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 39. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. CSL Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 41. Fountain Biopharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Fountain Biopharma Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 43. GlaxoSmithKline Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. GlaxoSmithKline Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 45. Hydra Biosciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Hydra Biosciences, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 47. Infinity Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Infinity Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 49. Kineta, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Kineta, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 51. Mabtech Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mabtech Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 53. Marinomed Biotechnologie GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Marinomed Biotechnologie GmbH Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 55. Mycenax Biotech Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Mycenax Biotech Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 57. NeoPharm Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. NeoPharm Co., Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 59. Oxagen Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Oxagen Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 61. Panacea Biotec Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Panacea Biotec Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed